Deciphera Pharmaceuticals (NASDAQ:DCPH) has been successfully acquired by Japan's Ono Pharmaceutical.

The acquisition was finalized following a tender offer priced at $25.60 per share, with approximately 88.3% of Deciphera's common stock being tendered.

Effective June 11, 2024, Deciphera Pharmaceuticals' shares have been removed from the Nasdaq Global Select Market as the company transitions to become a wholly-owned subsidiary of Ono Pharmaceutical.